HPK1-IN-58 is an inhibitor of HPK1 (IC50: 2.6 nM) and SLP76 (IC50: 20 nM). It enhances IL-2 secretion, thereby reversing PGE2-induced immunosuppression. HPK1-IN-58 is applicable for research in antitumor immunity.
Formula:
C26H30N8O
Target:
MAPK|||Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted